April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...
April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new ...
April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...
April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over ...
March 29, 2024 — Young adults who were prescribed stimulant medications for attention-deficit/hyperactivity disorder (AD ...
March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...
March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug ...
March 28, 2024 —  Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...
March 27 2024 — HeartFlow, Inc., a leader in AI-driven healthcare technology, announced the launch of the DECIDE ...
March 26, 2024 — Esperion announced the acceptance of three CLEAR (Cholesterol Lowering via Bempedoic acid, an ACL ...
March 26, 2024 — Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II ...
The American College of Cardiology (ACC) has announced key educational and programming highlights for its ACC 73rd ...
March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials ...